Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Transfusion

Results: 1-25/807

Authors: CLAY ME SMITH J DRAGOVICH S EDMAN L STRONCEK DF MCCULLOUGH J
Citation: Me. Clay et al., APHERESIS CENTER CHANGES TO ACCOMMODATE COLLECTION OF PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MOBILIZED DONORS, Transfusion, 37(9), 1997, pp. 1-1

Authors: STRAMER SL ABERLEGRASSE J BRODSKY JP BUSCH MP LACKRITZ EM
Citation: Sl. Stramer et al., US BLOOD-DONOR SCREENING WITH P24 ANTIGEN (AG) - ONE-YEAR EXPERIENCE, Transfusion, 37(9), 1997, pp. 1-1

Authors: DODD RY GRIFFIN GD CONRAD A SMITH RIF PAGE PL STRAMER SL
Citation: Ry. Dodd et al., PILOT-STUDY TO DETERMINE THE FEASIBILITY OF PCR TESTING OF POOLED DONOR SAMPLES FOR HBV,HCV,HAV AND PARVOVIRUS B19, Transfusion, 37(9), 1997, pp. 2-2

Authors: ANDING K VAUGHN L
Citation: K. Anding et L. Vaughn, HAVE TRUCK, WILL TRAVEL - MANAGEMENT OF A REGIONAL THERAPEUTIC APHERESIS PROGRAM, Transfusion, 37(9), 1997, pp. 2-2

Authors: BEELER SA GIANDELONE JA AXELROD FB
Citation: Sa. Beeler et al., A BLOOD CENTERS MOTIVATION TOWARD TOTAL APHERESIS COLLECTION, Transfusion, 37(9), 1997, pp. 3-3

Authors: MAASKANTVANWIJK PA FAAS BHW DERUIJTER JAM OVERBEEKE MAM VONDEMBORNE AEGK VANRHENEN DJ VANDERSCHOOT CE
Citation: Pa. Maaskantvanwijk et al., RHD GENOTYPING BY MULTIPLEX PCR ANALYSIS OF ALL RHD SPECIFIC EXONS, Transfusion, 37(9), 1997, pp. 3-3

Authors: DAVENPORT RD KUNKEL SL
Citation: Rd. Davenport et Sl. Kunkel, CHARACTERIZATION OF A MURINE MODEL OF HEMOLYTIC TRANSFUSION REACTIONS, Transfusion, 37(9), 1997, pp. 4-4

Authors: DAVIS J ROYER P CLEGG V
Citation: J. Davis et al., EMPOWERING THE TELERECRUITER, Transfusion, 37(9), 1997, pp. 4-4

Authors: MURAD KL MAHANY KL BRUGNARA C KUYPERS F EATON JW SCOTT MD
Citation: Kl. Murad et al., ANTIGENIC MODULATION OF ERYTHROCYTES VIA COVALENT BINDING OF NONIMMUNOGENIC MATERIALS, Transfusion, 37(9), 1997, pp. 5-5

Authors: BURN PH MENOZZI D
Citation: Ph. Burn et D. Menozzi, 2ND FINGERSTICK DECREASES HEMOGLOBIN DEFERRAL RATE USING HEMOCUE, Transfusion, 37(9), 1997, pp. 5-5

Authors: SULLIVAN MT SCHONBERGER LB KESSLER D WILLIAMS AE DODD RY
Citation: Mt. Sullivan et al., CREUTZFELDT-JAKOB-DISEASE (CJD) INVESTIGATIONAL LOOKBACK STUDY, Transfusion, 37(9), 1997, pp. 6-6

Authors: GEYER ME YRIONDO LD
Citation: Me. Geyer et Ld. Yriondo, THE INTERNET - A NEW APPROACH FOR BLOOD CENTERS IN MARKETING, EDUCATION AND DONOR RECRUITMENT, Transfusion, 37(9), 1997, pp. 6-6

Authors: SEMPLE J COSGRAVE D SPECK E BLANCHETTE V FREEDMAN J
Citation: J. Semple et al., EXTREME LEUKOREDUCTION ENHANCES MURINE PLATELET IMMUNITY - A HERETICAL REAPPRAISAL OF THE TARGET THRESHOLD DOSE OF CONTAMINATING LEUKOCYTES, Transfusion, 37(9), 1997, pp. 7-7

Authors: KRUEKEBERG N BOWERSOCK MA
Citation: N. Kruekeberg et Ma. Bowersock, BATTLE OF THE BADGES, Transfusion, 37(9), 1997, pp. 7-7

Authors: GOODNOUGH LT KUTER DJ DESPOTIS GJ DIPERSIO JF ROMO L TERRY D SHERIDAN W
Citation: Lt. Goodnough et al., SUCCESS IN RECRUITING COMMUNITY PLATELET DONORS TO PARTICIPATE IN CLINICAL-TRIALS OF MPL LIGAND (PEG-RHUMGDF) THERAPY IN HOSPITAL-BASED APHERESIS, Transfusion, 37(9), 1997, pp. 8-8

Authors: TOMITA D PETRARCA M PAINE T OLSON K ROSKOS L CHEUNG E KISICKI J
Citation: D. Tomita et al., EFFECT OF A SINGLE-DOSE OF PEGYLATED HUMAN RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ON PLATELET COUNTS - IMPLICATIONS FOR PLATELET APHERESIS, Transfusion, 37(9), 1997, pp. 8-8

Authors: MORELATI F REVELLI N MAFFEI LM PORETTI M SANTORO C REBULLA P PARRAVICINI A SIRCHIA G
Citation: F. Morelati et al., EVALUATION OF TECHNICIAN TIME OF A WALK-AWAY INSTRUMENT FOR PRETRANSFUSION TESTING, Transfusion, 37(9), 1997, pp. 9-9

Authors: GUTENSOHN K ALISCH A RAUHOEFT C GOEPFERT C KUEHNL P
Citation: K. Gutensohn et al., A FLOW CYTOMETRIC BIOCOMPATIBILITY PROFILE OF THE AMICUS(TM) BLOOD-CELL SEPARATOR, Transfusion, 37(9), 1997, pp. 9-9

Authors: CURRIE LM VADHANRAJ S LIVESEY SA CONNOR J
Citation: Lm. Currie et al., CRYOPRESERVATION OF PLATELETS FROM RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO)-TREATED DONORS USING THROMBOSOL(TM) AND 2-PERCENT DMSO, Transfusion, 37(9), 1997, pp. 10-10

Authors: REBULLA P TIBALDI S LECCHI L COLOTTI G SIRCHIA G
Citation: P. Rebulla et al., COST OF CORD-BLOOD UNITS RELEASED FOR TRANSPLANTATION, Transfusion, 37(9), 1997, pp. 10-10

Authors: EASTLUND T DINKFELT P ARNESON T
Citation: T. Eastlund et al., CHANGES IN BLOOD ORDERING AND TRANSFUSION PRACTICES FOR PRIMARY TOTALKNEE REPLACEMENT, Transfusion, 37(9), 1997, pp. 11-11

Authors: PAGLIERONI TG FERNANDO L GRESENS C KWIATKOWSKA B SCHUERMANN T MACKENZIE MR RICHMAN C WUN T SAYEGH A
Citation: Tg. Paglieroni et al., EFFECTS OF G-CSF ON SEROLOGIC TESTS FOR INFECTIOUS-DISEASE MARKERS, Transfusion, 37(9), 1997, pp. 11-11

Authors: URDAHL SG ZEMAN JD
Citation: Sg. Urdahl et Jd. Zeman, COST COMPARISON OF AUTOMATED DOUBLE RED-BLOOD-CELL COLLECTION AND WHOLE-BLOOD PRODUCTS, Transfusion, 37(9), 1997, pp. 12-12

Authors: VARGAS SO CANNON ME BENJAMIN RJ LONGTINE JA
Citation: So. Vargas et al., TRANSFUSION WITH BLOOD FROM A DONOR WITH CHRONIC MYELOGENOUS LEUKEMIA- PERSISTENCE OF THE BCR ABL TRANSLOCATION IN THE RECIPIENT/, Transfusion, 37(9), 1997, pp. 12-12

Authors: KANTER M VANMAANEN D ANDERS KH CASTRO F MYA WW CLARK K
Citation: M. Kanter et al., EFFECT OF DECREASING PREOPERATIVE AUTOLOGOUS DONATIONS ON SUBSEQUENT TRANSFUSION RATES, Transfusion, 37(9), 1997, pp. 13-13
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>